Cookies Policy

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.

I accept this policy

Find out more here

Ethical Ramifications for a Proposed FTA between India and the EU

No metrics data to plot.
The attempt to load metrics for this article has failed.
The attempt to plot a graph for these metrics has failed.
The full text of this article is not currently available.

Brill’s MyBook program is exclusively available on BrillOnline Books and Journals. Students and scholars affiliated with an institution that has purchased a Brill E-Book on the BrillOnline platform automatically have access to the MyBook option for the title(s) acquired by the Library. Brill MyBook is a print-on-demand paperback copy which is sold at a favorably uniform low price.

Access this article

+ Tax (if applicable)
Add to Favorites
You must be logged in to use this functionality

image of Perspectives on Global Development and Technology
For more content, please see Journal of Developing Societies.

AbstractAwareness about the global burden of disease highlights an important relationship between the needs of the desperately ill in economically disadvantaged countries and the need to ensure adequate compensation for the research and development of new medicines. Although the UN officially recognizes the Right to Health as a fundamental human right, I argue that it is simultaneously undermining its official position by enabling wealthy nations to take advantage of unfair bargaining positions in trade negotiations. Where such agreements target the epicenter for the creation and distribution of medicines for the globally disadvantaged, they must be viewed as particularly reprehensible.

Affiliations: 1: Simon Fraser


Full text loading...


Data & Media loading...

1. Agreement on Trade-Related Aspects of Intellectual Property Rights "Marrakesh Agreement Establishing the World Trade Organization, Annex 1C" 1994 Retrieved April 11, 2011 ( ) (April 15)
2. Central Intelligence Agency "The World Factbook page on India, Section: People and Society" 2011 World Factbook [Online database] n.d. Retrieved April 11, 2011 ( )
3. Childs Michelle "“Towards a Patent Pool for HIV Medicines: The Background”" The Open AIDS Journal 2010 Vol 4 33 36 doi:1874-6136/10
4. DiMasi Joseph A. , Hansen Ronald W. , Grabowski Henry G. "“The price of innovation: new estimates of drug development costs”" Journal of Health Economics 2003 March Vol 22 2 151 185 doi:10.1016/S0167-6296(02)00126-1
5. Doctors Without Borders "“EU-India Free Trade Agreement: Last Chance to Unblock Access to Medicines”" 2010 April 26 Retrieved April 11, 2011 ( )
6. European Commission Webpage on bilateral trade relations with India n.d. Retrieved April 11, 2011 ( )
7. European Generic Medicines Association n.d. Retrieved April 11, 2011 ( )
8. Free Trade, Drugs and India The Wall Street Journal 2010 December 31 Retrieved April 11, 2011 ( )
9. Love James "“The Production of Generic Drugs in India: A New Trade Agreement with the EU Would Hinder Access to Drugs in Developing Countries”" British Medical Journal 2011 March 22 Vol 342 doi:10.1136/bmj.d1694
10. Nair Gopakumar G. "“Indian Patent Law and Pharma Industry”" 2003 May 29 Retrieved April 11, 2011 ( )
11. Peterson Matt "“What’s Ailing the EU-India Free Trade Agreement”" 2011 March 29 Retrieved April 11, 2011 ( )
12. Pogge Thomas "“Access to Medicines”" Public Health Ethics 2008 July Vol 1 2 73 82 doi:10.1093/phe/phn023
13. "Preliminary Consultation Draft on IPR Chapter of India-EU Broad-based Trade and Investment Agreement" 2010 April 23 Retrieved April 11, 2011 ( )
14. Radhakrishnan Priti "“India and Second-Line ART”" 2007 March Retrieved April 11, 2011 ( )
15. Sampat Bhaven N. "“Institutional Innovation or Institutional Imitation? The Impacts of TRIPs on India’s Patent Law and Practice”" 2010 July Retrieved April 11, 2011 ( )
16. "Thousands protest against EU-India Free Trade Agreement (FTA)" 2011 March Retrieved April 11, 2011 ( )
17. United Nations Office of the High Commissioner for Human Rights n.d. Retrieved April 11, 2011 ( )
18. United Nations Office of the High Representative for the Least Developed Countries, Landlocked Developing Countries and Small Island Developing States n.d. Retrieved March 31, 2011 ( )
19. United Nations Office of the High Representative for the Least Developed Countries, Landlocked Developing Countries and Small Island Developing States "“LDC Factsheet”" 2011 Retrieved April 11, 2011 ( )
20. United States Department of State Webpage on Switzerland, Section: Economy n.d. Retrieved April 11, 2011 ( )
21. World Health Organization "Prioritizing Second-Line Antiretroviral Drugs for Adults and Adolescents: a Public Health Approach" Report of a World Health Organization Working Group Meeting. Geneva, Switzerland 2007 May 21-22 Retrieved April 11, 2011 ( )
22. World Trade Organization "Declaration on the TRIPS Agreement and Public Health" 2001 November 20 World Trade Organization Ministerial Conference, Fourth Session Doha, Qatar Retrieved April 11, 2011 ( )
23. World Trade Organization "TRIPS and pharmaceutical patents" 2006 September Fact Sheet. Retrieved April 11, 2011 ( )

Article metrics loading...



Can't access your account?
  • Tools

  • Add to Favorites
  • Printable version
  • Email this page
  • Subscribe to ToC alert
  • Get permissions
  • Recommend to your library

    You must fill out fields marked with: *

    Librarian details
    Your details
    Why are you recommending this title?
    Select reason:
    Perspectives on Global Development and Technology — Recommend this title to your library
  • Export citations
  • Key

  • Full access
  • Open Access
  • Partial/No accessInformation